KPV
LIMITED EVIDENCEAlso known as: Lys-Pro-Val, alpha-MSH fragment
Investigational — not approved for human use
Educational Overview
A short tripeptide fragment of alpha-MSH studied in preclinical models for inflammatory signalling.
Research Mechanism
Preclinical work explores anti-inflammatory signalling pathways; controlled human data is minimal.
Areas of Study
- Inflammatory models (animal)
- Skin and gut models (preclinical)
Safety Considerations
Human safety is not established. Research material only.
Frequently Asked Questions
Is KPV studied in humans?
Controlled human evidence is essentially absent; most work is preclinical.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-06-01 · Status: draft · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.